Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes

NCT04567628 · clinicaltrials.gov ↗

COMPLETED

Status

7873

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Diseases
Colitis, Ulcerative
Crohn Disease

Interventions

OTHER: No Intervention

Sponsor

Takeda